Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy
| Image |  |
|---|---|
| Description | scientific article published on 26 August 2020 |
| Author/s |
author: Kwangmeyung Kim |
| Publication date | August 26, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |